JPMorgan Chase & Co’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,661,842
| Closed | -$79.8M | – | 5170 |
|
|
2020
Q1 | $79.8M | Buy |
1,661,842
+737,417
| +80% | +$35.4M | 0.02% | 607 |
|
|
2019
Q4 | $43.4M | Buy |
924,425
+669,765
| +263% | +$31.4M | 0.01% | 929 |
|
|
2019
Q3 | $6.02M | Buy |
254,660
+9,709
| +4% | +$230K | ﹤0.01% | 2081 |
|
|
2019
Q2 | $7.03M | Buy |
244,951
+5,682
| +2% | +$163K | ﹤0.01% | 1937 |
|
|
2019
Q1 | $5.36M | Buy |
239,269
+678
| +0.3% | +$15.2K | ﹤0.01% | 2064 |
|
|
2018
Q4 | $4.34M | Sell |
238,591
-75,109
| -24% | -$1.37M | ﹤0.01% | 2179 |
|
|
2018
Q3 | $5.67M | Buy |
313,700
+51,010
| +19% | +$923K | ﹤0.01% | 2174 |
|
|
2018
Q2 | $2.61M | Sell |
262,690
-173,401
| -40% | -$1.73M | ﹤0.01% | 2641 |
|
|
2018
Q1 | $2.32M | Buy |
436,091
+162,714
| +60% | +$864K | ﹤0.01% | 2657 |
|
|
2017
Q4 | $2.32M | Buy |
273,377
+17,077
| +7% | +$145K | ﹤0.01% | 2668 |
|
|
2017
Q3 | $3.74M | Buy |
256,300
+56,400
| +28% | +$823K | ﹤0.01% | 2331 |
|
|
2017
Q2 | $3.75M | Buy |
199,900
+50,432
| +34% | +$945K | ﹤0.01% | 2292 |
|
|
2017
Q1 | $3.18M | Sell |
149,468
-17,348
| -10% | -$369K | ﹤0.01% | 2357 |
|
|
2016
Q4 | $2.53M | Buy |
+166,816
| New | +$2.53M | ﹤0.01% | 2536 |
|